ARTEMIS MRI-TRUS Fusion Biopsy: Advancing Prostate Cancer Diagnostics Across Europe

 

Meeting the Evolving Needs of European Urology

Prostate cancer remains a leading health concern across Europe, necessitating diagnostic tools that are both precise and adaptable to diverse clinical settings. The ARTEMIS MRI-TRUS Fusion Biopsy system addresses these needs by integrating multiparametric MRI with real-time ultrasound, offering enhanced accuracy in detecting clinically significant prostate cancers. ​PMC

Key Advantages of ARTEMIS for European Healthcare Providers

Enhanced Detection Accuracy

  • Targeted Biopsies: ARTEMIS enables precise targeting of MRI-identified lesions, improving the detection rate of significant prostate cancers. ​

  • Reduced Overdiagnosis: By focusing on clinically relevant areas, the system minimizes the identification of indolent tumors, aligning with best practices in patient care.​

Seamless Integration into Clinical Workflows

  • Flexible Biopsy Approaches: Supports both transrectal and transperineal procedures, allowing clinicians to choose the most appropriate method for each patient. ​

  • Compatibility: Integrates with existing hospital information systems, ensuring smooth adoption without disrupting current workflows.​

Improved Patient Experience

  • Minimally Invasive: The fusion-guided approach reduces the number of necessary biopsy cores, decreasing patient discomfort and recovery time.​StraitsResearch+1eigen.com+1

  • Lower Complication Rates: Studies have shown a decrease in post-procedural complications compared to traditional biopsy methods. ​

Aligning with European Standards and Guidelines

ARTEMIS is designed in accordance with the European Association of Urology (EAU) guidelines, which recommend MRI-targeted biopsies for patients with elevated PSA levels and prior negative biopsies. The system's precision and adaptability make it a valuable asset in meeting these standards. ​

Economic Considerations for European Healthcare Systems

  • Cost-Effectiveness: By improving diagnostic accuracy, ARTEMIS reduces the need for repeat procedures and overtreatment, leading to overall cost savings.​

  • Resource Optimization: Efficient procedures free up clinical resources, allowing healthcare providers to serve more patients without compromising quality.​

Proven Success Across Europe

Numerous healthcare institutions across Europe have successfully integrated ARTEMIS into their diagnostic processes, reporting enhanced detection rates and improved patient outcomes. These real-world applications underscore the system's effectiveness and adaptability in various clinical environments.​

Learn More About ARTEMIS

Комментарии

Отправить комментарий